|
Market Closed -
NSE India S.E.
11:05:09 28/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 10.34 INR | -1.80% |
|
-6.51% | -46.73% |
Business description: Nectar Lifesciences Limited

Number of employees: 111
Sales by Activity: Nectar Lifesciences Limited
| Fiscal Period: March | 2022 (INR) | 2023 (INR) | 2024 (INR) | 2025 (INR) | 2026 (INR) |
|---|---|---|---|---|---|
Pharmaceuticals Products | 16.69B | 15.24B | 16.85B | 16.7B | - |
Geographical breakdown of sales: Nectar Lifesciences Limited
| Fiscal Period: March | 2022 (INR) | 2023 (INR) | 2024 (INR) | 2025 (INR) | 2026 (INR) |
|---|---|---|---|---|---|
India | 11.81B | 8.45B | 11.46B | 11.72B | - |
Outside India | 7.45B | 9.01B | 7.79B | 7.37B | - |
Executive Committee: Nectar Lifesciences Limited
| Manager | Title | Age | Since |
|---|---|---|---|
Sushil Kapoor
DFI | Director of Finance/CFO | 68 | 13/11/2022 |
| Compliance Officer | - | 31/03/2025 |
Composition of the Board of Directors: Nectar Lifesciences Limited
| Director | Title | Age | Since |
|---|---|---|---|
Sanjiv Goyal
CHM | Chairman | 66 | 26/06/1995 |
Rupinder Tewari
BRD | Director/Board Member | 69 | 10/02/2019 |
| Director/Board Member | 75 | 20/09/2021 | |
Indu Pal Kaur
BRD | Director/Board Member | 61 | 01/08/2022 |
Company details: Nectar Lifesciences Limited

Generic Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.80% | -6.51% | -27.69% | -54.25% | 21.54M | ||
| +0.50% | +1.38% | +57.09% | +129.96% | 1,143B | ||
| +0.86% | +5.14% | +45.00% | +86.15% | 647B | ||
| -0.14% | +0.42% | +25.69% | +105.85% | 506B | ||
| -0.05% | +2.28% | +49.14% | +67.74% | 384B | ||
| -0.63% | -5.97% | +61.93% | +37.06% | 350B | ||
| +0.34% | +2.15% | +25.26% | +54.27% | 293B | ||
| -0.45% | +1.16% | +1.74% | +26.08% | 265B | ||
| +0.87% | +3.08% | +54.69% | +72.74% | 242B | ||
| +0.08% | +3.67% | +35.05% | +107.78% | 197B | ||
| Average | -0.04% | +0.28% | +32.79% | +63.34% | 402.76B | |
| Weighted average by Cap. | +0.25% | +0.71% | +43.68% | +89.02% |
- Stock Market
- Stocks
- NECLIFE Stock
- Company Nectar Lifesciences Limited
Select your edition
All financial news and data tailored to specific country editions

















